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Abstract 
 
Purpose: To examine the prevalence, sociodemographic and clinical predictors, and physical 
and psychosocial correlates of unmet needs among women 3-5 years following treatment for 
endometrial cancer.  
Methods: Women with endometrial cancer completed a survey around the time of diagnosis 
and again 3–5 years later. The follow-up survey asked women about their physical and 
psychosocial functioning and supportive care needs (CaSUN). Multivariable-adjusted logistic 
regression identified the predictors and correlates of women’s unmet needs 3-5 years after 
diagnosis.  
Results: Of the 629 women who completed the CaSUN, 24% (n=153) women reported one or 
more unmet supportive care needs in the last month. Unmet needs at 3-5 years post-diagnosis 
were predicted by younger age (OR=4.47; 95% CI:2.09-9.56) and advanced disease stage at 
diagnosis (OR=2.47; 95% CI:1.38-4.45) and correlated with greater cancer symptoms (OR= 
1.78; 95% CI: 1.05-3.02); lower-limb swelling (OR=2.50; 95% CI:1.51-4.15); symptoms of 
anxiety (OR=2.21; 95% CI:1.31-3.72) and less availability of social support (OR=3.42; 95% 
CI:1.92-6.11). Women with a history of comorbidities (OR=0.47; 95% CI:0.27-0.82) and 
those living in a rural area at the time of diagnosis (OR=0.56; 95% CI:0.34-0.92) were less 
likely to report unmet needs.  
Conclusions: Sociodemographic, health and psychosocial factors seem important for 
identifying women who will, or will not have, unmet needs several years following 
endometrial cancer. Longitudinal assessments of people’s needs over the course of their 
cancer trajectory may be an effective way to identify areas that should receive further 
attention by health providers. 
 
Keywords: Endometrial cancer, gynecological cancer, supportive care needs, psychosocial  
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INTRODUCTION 
Endometrial cancers stem from the cells lining the uterus, with two common subtypes 
described [40]. Five-year survival rates among women are high and treatment is often well 
tolerated [1]; however, for some women treatment can be associated with significant long-
term reductions in quality of life, including bowel and urinary problems, lymphedema, and 
sexual concerns, contributing to reduced psychosocial wellbeing [28, 31]. Although quality of 
life measures are an effective way to assess the impact of having cancer on people’s physical, 
psychological and social wellbeing, asking women about their supportive care needs after 
cancer provides much needed context to what actions and resources might enhance or 
maintain wellbeing [32, 33]. Measures of cancer-specific supportive care needs examine, for 
example, how well the patient perceives their care and treatment; professional and social 
relationships and individual concerns across the cancer trajectory (e.g. fear of cancer 
recurrence) [8, 25]. Well-validated measures of supportive care needs are also highly 
correlated with, but distinct from measures of psychological distress and overall quality of 
life [6, 19]. Assessing supportive care needs can, therefore, identify areas where people 
require help and this information can inform psychosocial interventions and optimize health 
care practice [8].  
By comparison to breast cancer, relatively little is known about the supportive care 
needs of the large, and increasing, numbers of women living with endometrial cancer. A 
previous Australian study, found that women with endometrial cancer had more unmet 
supportive care needs 3 months to 5 years after diagnosis than women with other 
gynecological cancer types [3] and in two small, qualitative and mixed methods studies, 
women with endometrial cancer who were up to 5 years post-diagnosis described a need for 
follow-up appointments where information was offered to address their concerns [20, 39]. 
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However, there are no large, representative studies that quantify the long-term needs of 
women with endometrial cancer.  
Among women with breast cancer, younger age, advanced disease stage, greater 
symptom burden, shorter time since diagnosis, and higher levels of distress have been 
associated with greater needs [13]. Although younger age, advanced disease stage and 
psychological distress also appear strongly related to unmet needs among women with 
gynecological cancers [16, 37], the specific factors that may differentiate between women 
with and without unmet needs following endometrial cancer have not been examined. 
Although treatment side effects such as lymphedema are associated with reduced quality of 
life among women with gynecological cancer [12, 27], few studies have examined whether 
lymphedema is associated with increased supportive care needs beyond three years post-
diagnosis [3, 4], and none have focused specifically on women with endometrial cancer. 
Family and friends may play an important, positive role in alleviating women’s concerns 
following gynecological cancer, but the association between social support and women’s 
supportive care needs is inconsistent [3, 5].  
Supportive care needs can change over the course of the cancer trajectory [23] and 
can  differ among the gynecological cancer types [3]. The assessment of women’s needs 
several years following endometrial cancer is, therefore, important to determine the extent to 
which ongoing support is required. The study aims to examine the prevalence of supportive 
care needs among women 3-5 years following their diagnosis of endometrial cancer and to 
identify the sociodemographic, clinical, physical health and psychosocial factors associated 
with having unmet needs.  
METHODS 
The women described here are from the Australian National Endometrial Cancer 
Study (ANECS), an Australia-wide, population-based, case-control study of women diagnosed 
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with endometrial cancer between 2005 and 2007, with methods reported previously [30]. 
Briefly, women completed a survey around the time of diagnosis. About 3-5 years later, they 
were recontacted and invited to complete a follow-up survey regarding their current lifestyle, 
supportive care needs, and physical and psychological wellbeing [29]. Fig 1 shows the 
participant recruitment and retention for the study. Briefly, of the 1399 original ANECS 
participants, 1283 were still alive and of these, 644 women (50%) completed the survey. Of 
these, 629 (49%) provided valid data on the questions assessing women’s supportive care 
needs and are included in this analysis. Compared to women who did not respond to the 
follow-up survey or provide valid data (n = 654; excluding those who had died), those who 
did respond had higher levels of education and were more likely to have grade 3 cancers and 
to have had adjuvant treatment including brachytherapy alone and chemotherapy and/or 
radiation therapy or brachytherapy (all p < 0.05). There were no significant differences at the 
time of diagnosis between women who participated and those who did not on stage of disease 
and the other clinical or sociodemographic variables of interest. The study was approved by 
the Human Research Ethics Committees at the QIMR Berghofer Medical Research Institute 
and all participating hospitals.  
Measures 
Outcome variable (3-5 years post-diagnosis)  
Supportive Care Needs were assessed using the Cancer Survivors’ Unmet Needs 
(CaSUN) [19]. This 35-item self-administered questionnaire measures cancer-specific needs 
across five domains – existential survivorship, comprehensive cancer care, information, 
quality of life and relationships. Participants are asked to indicate for each item whether or 
not they had that specific need in the last month. Those who have a need are asked to report 
whether the need has been met or remains currently unmet, and those reporting an unmet 
need are asked to rate the strength of the need (weak, moderate or strong). The scale can be 
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used to calculate the number of total needs, met needs, unmet needs and strength of needs 
overall, and for the five subscales. Scores range from 0 – 35, with higher scores indicating a 
greater number of unmet needs. Overall the scale has high internal consistency (Cronbach’s 
alpha =  0.96) and the five subscales have satisfactory internal consistency with Cronbach’s 
alphas ranging between 0.78 and 0.93 [19].    
Time 1 variables (at diagnosis) 
Sociodemographic variables. Age, marital status, education, employment status, area 
of residence (urban, rural or remote), state of diagnosis and parity were collected at the initial 
survey around the time of diagnosis.  
Clinical variables.  Information on tumor stage and grade at diagnosis, surgery type 
(laparotomy, laparosopic or vaginal hysterectomy), treatment type (surgery, chemotherapy, 
radiotherapy, brachytherapy, other), and number of lymph nodes examined was abstracted 
from the diagnostic histopathology reports and medical records of consenting women. 
Time 2 variables (3-5 years post-diagnosis)  
Health and health-related variables 
Smoking status was self-reported and women were classified as current smokers, ex-
smokers, or never smokers.   
Body mass index (kg/m2) was calculated using women’s self-reported weight and 
height [coded as underweight/normal (<25), overweight (25-29.9), obese (≥30)]. 
Major comorbidities (e.g., heart disease, rheumatoid arthritis) as listed in the Charlson 
comorbidity index [10] were identified and counted to form one overall comorbidity score, 
categorized as “none”, “1” or “≥2” comorbidities.  
Cancer-specific physical wellbeing: A list of nine cancer symptoms (e.g. night sweats, 
trouble digesting food, urinary/bowel symptoms) from the Functional Assessment of Cancer 
Therapy Endometrial Cancer Subscale (FACT-EN) was used to assess physical well-being in 
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the previous four weeks [9]. Responses are on a five-point Likert scale ranging from 1 (not at 
all) to 4 (very much) with a maximum score of 36. Scores are recoded so that higher scores 
indicate better physical functioning. For the current analysis, the overall score was split 
according to the sample median (score 33) because data were not normally distributed; 
women with scores below the median were classified as having lower levels of physical 
wellbeing.  
Lymphedema. A series of questions, with satisfactory face validity, from another 
Australian study of women with gynecological cancer [4] was used to categorize women into 
three groups: without lymphedema or lower limb swelling; lower limb swelling only; 
medically diagnosed lower limb lymphedema.  
Psychosocial variables 
Symptoms of anxiety and depression were assessed using the Hospital Anxiety and 
Depression Scale (HADS) [42], a 14-item measure of psychological distress that is widely 
used among people with cancer [38]. Higher scores represent greater psychological distress 
and the following cut-offs are used to define clinical symptom levels of anxiety and 
depression:  Normal (0-7), subclinical depression/anxiety (8-10), clinical depression/anxiety 
(11-21).  
Social support. The question, “Is there someone available to you whom you can count 
on to listen to you when you need to talk?” was used as a proxy for current level of social 
support (categorized as: none/little/some vs. all of the time). 
Statistical analysis 
Women were categorized, first, as having “no need” or “a need” and then those 
reporting a need were further classified according to whether these needs were “met” or 
“unmet”. Binary logistic regression was used to screen the potential correlates of having at 
least one unmet need in any domain. Because of the low prevalence of unmet needs, we did 
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not conduct separate analyses to examine the correlates of unmet needs within each of the 
five need domains. Those variables significant (p <0.05) in these analyses were entered into a 
multivariable logistic regression model to examine the inter-correlations among the variables 
and their associations with having unmet needs. Variables that remained significant in these 
models, or that were considered theoretically relevant, were retained for further analysis. The 
only exception was for treatment variables where stage, number of lymph nodes removed and 
adjuvant treatment were highly correlated, so only stage was retained. The final model was 
reduced to only those variables that were theoretically relevant or statistically significant. All 
statistical analyses were performed using SAS version 9·2 (SAS Institute Inc., Cary, NC, 
USA). 
RESULTS 
Participant characteristics 
Table 1 shows the characteristics of participating women around the time of 
diagnosis. Most women had stage I (85%) cancers and more than half had surgery without 
adjuvant treatment (67%). At diagnosis, around half of the women were between 50 and 65 
years (55%), most had a partner (71%) and lived in urban areas (64%) and 48% had a high 
school education. At the follow-up survey, women were on average 4.1 years post-diagnosis 
(SD = 0.7, range = 2.9–6.3 years). 
 Prevalence of needs 
Overall, 56% (n=351) of women reported at least one need: 31% (n=198) reported 
that their all needs were currently being met and 24% (n= 153) reported an unmet need in the 
last month, with 20% (n = 128) reporting that the strength of the unmet need was moderate-
to-high.  
Table 2 shows the needs, met and unmet, reported by the women 3-5 years following 
their diagnosis. Although the most common needs were in the comprehensive cancer care 
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domain these were also the needs that were most likely to be met (by 78-81% of those with a 
need). These included a need to know that their doctors were talking to each other to 
coordinate their care; to feel like they were maintaining their health together with the medical 
team; access to local health care services when required and the very best medical care. 
Women reported the highest unmet needs in the existential survivorship domain and specific 
items included a need to reduce stress in their lives (8.3%); cope with others not 
acknowledging the impact that cancer had on their lives (7.9%) and manage concerns about 
the cancer coming back (7.2%). The relationship and comprehensive cancer care domains 
were also endorsed with women needing help to address problems with their sex lives (7.5%) 
and accessible hospital parking (6.6%).  
Predictors and correlates of unmet needs 
Table 3 shows the predictors and correlates of having at least one unmet need during 
the last month. Unadjusted logistic regression analyses showed that women who were 
younger, with higher levels of education and who were in the workforce at the time of 
diagnosis had higher odds of reporting an unmet need whereas women living in rural or 
remote areas had lower odds of reporting an unmet need than women in major cities. In 
addition, women who had an advanced stage of disease at diagnosis, 15 or more lymph nodes 
removed, adjuvant treatment, who were current smokers, had lower levels of physical 
wellbeing and lower-limb lymphedema or lower-limb swelling also had higher odds of 
reporting an unmet need. Women with comorbidities had lower odds of reporting an unmet 
need whereas women reporting symptoms of anxiety and depression and less availability of 
social support had higher odds of reporting an unmet need. Parity, surgery type, grade of 
cancer and BMI were not associated with having unmet needs.  
The final, adjusted model, showed that having at least one unmet need was predicted 
by sociodemographic and clinical factors. Women with higher odds of reporting an unmet 
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need at 3-5 years post-diagnosis were those who were younger and who had advanced disease 
at the time of diagnosis while women residing in rural or remote areas were less likely to 
have unmet needs. In addition, physical health and psychosocial factors were strongly 
correlated with unmet needs: Women who reported lower levels of physical functioning, 
lower-limb swelling, more symptoms of anxiety and less availability of social support were 
more likely to report unmet needs whereas women with a history of comorbidities were less 
likely to report unmet needs. Taking into account these variables, employment status, level of 
education, parity, adjuvant treatment, number of lymph nodes removed, smoking and 
depressive symptoms were not significantly associated having at least one unmet need. 
DISCUSSION 
Among these women with endometrial cancer who were surveyed 3-5 years after 
diagnosis, 56% reported having one or more needs in the last month and, of these, most 
reported that their needs were largely being met by existing health care professionals and 
services. A quarter of women reported at least one unmet need in the last month. Another 
study using the CaSUN to assess the supportive care needs of people with varying types of 
cancer also found that the prevalence of unmet needs was relatively low (47%) at five or 
more years after diagnosis, particularly for those who had a more favorable prognosis [15]. 
The prevalence of unmet needs in our study is noticeably lower than has been reported in 
other studies of women with gynecological cancers (52%-56%) [16, 37], which may be due 
to the variations among these studies regarding the time since diagnosis when needs were 
assessed, the specific questionnaire used, the time since diagnoses, or the variable treatment 
and prognostic factors for women with cancers at different gynecological sites.  
While the prevalence of unmet needs was comparatively lower, women’s needs were 
similar to what has been reported in other studies of people with reproductive cancers [16, 
35]. In our study, the top five most commonly reported need items were largely related to 
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comprehensive care and to a lesser extent existential issues, whereas unmet needs were more 
commonly related to existential issues (than to comprehensive care). Specifically, the longer-
term unmet needs of the women in our study were largely related to their psychosocial 
wellbeing. At 3-5 after their diagnosis, some women wanted greater acknowledgement from 
others of their experience of cancer, or needed help dealing with their own or others 
expectations of them as a “cancer survivor”. In a qualitative analysis of free-text comments 
from a subset of these same women [28] we also found that many women described 
difficulties coping with the long-term effects of cancer while others were not focused on their 
cancer and struggled to form meaningful identities post-cancer in the context of a cancer 
“survivorship” culture [28] . Family and health care professionals may, therefore, need to be 
mindful about the diversity of women’s experiences and the potential negative impact of 
cancer survivorship stereotypes on women’s lives [21].  
Although slightly more than half of women felt that their need for help with managing 
their concerns that the cancer might come back was being met, this was the fourth most 
common unmet need among women. Fears of cancer recurrence are common among many 
people treated for cancer, irrespective of the type or severity of the cancer [2, 33], and our 
findings reinforce the importance of acknowledging this, regardless of the time since 
diagnosis or the medical prognosis of the patient. Women also reported having an unmet need 
for help when trying to make decisions about their life in the context of uncertainty. Most 
women diagnosed with endometrial cancer have a favorable prognosis, and their need for 
reassurance about being cured may be overlooked several years following their diagnosis, or 
not well understood, by family and health professionals. Other studies have found that 
women want more opportunities for follow-up appointments [39]; this may offer women the 
opportunity to have their concerns and needs validated and addressed.  
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Sociodemographic, health and psychosocial factors were important for identifying 
women who did, and did not have, unmet needs several years following endometrial cancer. 
Consistent with previous studies of women with breast [13] and gynecological cancer [16, 
37], younger women, those with more advanced disease at diagnosis, and those with lower 
levels of physical wellbeing and symptoms of anxiety 3-5 years following their diagnosis 
were more likely to report one or more unmet needs in the long-term survivorship phase. 
Women who had less social support available to them were also more likely to report unmet 
needs and this has been reported in other studies [14, 34]. Increasing social support may, 
therefore, reduce women’s need for help by improving psychosocial wellbeing. Social 
support has also been associated with increased quality of life [24] and also possibly cancer 
survival [22]. Interventions that mobilize social and health care support may, therefore, 
provide multi-level benefits across the cancer trajectory.  
Support for women with symptoms similar to lymphedema may be particularly 
important. In this study, women who self-reported lower-limb swelling without a diagnosis of 
lymphedema were more likely to have unmet needs. This is consistent with a previous 
analysis we conducted, which showed that these women reported lower levels of physical and 
mental health than women without lymphedema or swelling [27]. While a previous study 
showed that undiagnosed lower limb swelling was not associated with unmet needs, the 
majority of women in that study were less than three post-diagnosis [3]. Our data may 
suggest that symptom burden at 3-5 years after diagnosis increases women’s need for support 
for physical, emotional and social difficulties.  
 Somewhat unexpectedly, women from rural or remote areas and those with 
comorbidities were less likely to report unmet needs 3-5 following their diagnosis. While 
women living in rural areas tend to have more limited access to health services than women 
from major cities, and their expectations for support may be lowered [7], they may have a 
13 
 
greater sense of community connectedness and participation in their community  [26, 41], 
which may enable them to gain help for emotional and relationship difficulties. Similarly, 
women with comorbidities may have prior experience with the health care system or effective 
health care support already accessible to them. Alternatively, comorbidites may take 
precedence over the cancer. We have previously found that some women with endometrial 
cancer describe their comorbidities as having a greater physical and psychosocial impact on 
their lives than the cancer [28]. Consequently, their focus is on their pre-existing health 
condition and not their cancer. In support of this, is the finding that women reporting reduced 
cancer-specific physical wellbeing were more likely to have unmet needs, suggesting that the 
CaSUN effectively distinguishes between supportive care needs that are, and are not, 
associated with the cancer.   
Although this study included a large sample of women with endometrial cancer from 
across Australia, we had a relatively low response rate (50%), which is consistent with other 
studies using mailed surveys [11, 33].  Women who participated were more likely to have 
grade 3 cancers and to have had adjuvant treatment than those who did not. The higher 
refusal rates among women low grade cancers may suggest that they had moved on with their 
lives and were, therefore, less likely to have needs. Similarly, because education was related 
to greater needs in our study, it is possible that we have over-estimated the prevalence of 
needs.   
Overall, although around half of women with endometrial cancer had at least one 
supportive care need several years after their diagnosis, most women reported that these 
needs were being met. Women who had unmet needs reported needing help with personal 
and social aspects of their lives and having no or little social support available was associated 
with unmet needs. Health professionals may assist by directing women to the support services 
available within their community as well as providing women with reputable sources of 
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online support and information. Examining the types of social support and people most 
helpful to women following endometrial cancer, in conjunction with needs assessments of 
family members [17, 18, 35, 36], may provide a rich picture of how to effectively support 
women following endometrial cancer. Because needs may change in response to effective 
support, this also reinforces the value of longitudinal assessments of people’s needs over the 
course of their cancer trajectory to effectively identify areas that should receive further 
attention by health providers.  
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Fig 1 Flow of participant recruitment  
 
 
 
Australia National Endometrial Cancer Study 
(N=1399) 
Quality of Life follow-up survey (3-5 years post-diagnosis) 
Eligible: N= 1283  
Final group  
N = 644 
Excluded due to missing data (n = 15) 
 
Not contactable (n= 355) 
Chose not to participate (n = 258)  
Too sick (n= 26)  
Died (n= 116) 
Analysed  
n = 629 
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Table 1. Characteristics of women who did, and did not, respond to the follow-up 
survey at the time of diagnosis (N = 629) 
 Respondents  
(N = 629)  
Non-respondentsa 
(N= 654) 
 
 nb % nb % p 
Age (years)     0.07 
     <50 61 10 90 14  
50-65 346 55 335 51  
     >65 222 35 229 35  
      
Relationship status     0.20 
Partnered  438 71 423 68  
No partner 176 29 199 32  
      
Education (highest level 
completed) 
     
0.003 
High school 302 48 368 56  
Technical college/University   327 52 286 44  
      
Area of residence     0.46 
Major city   397 64 399 62  
Rural or remote centre 220 36 241 38  
      
State recruited in     0.84 
New South Wales 135 21 139 21  
Queensland 193 31 214 33  
Victoria 148 24 135 21  
South Australia 68 11 69 11  
Western Australia 58 9 66 10  
Tasmania 27 4 31 5  
      
Stage of disease at diagnosis (FIGO 2009)    0.04 
I 530 85 573 88  
II-IV 98 16 76 12  
      
Grade of disease at diagnosis    0.002 
Well differentiated 326 52 382 59  
Moderately differentiated 163 26 173 27  
Poorly differentiated 140 22 97 15  
      
Surgery      0.12 
Laparotomy 417 67 402 63  
Laparoscopic/vaginal 
hysterectomy 
205 33 238 37  
      
Adjuvant treatment      0.03 
No 399 65 453 72  
Brachytherapy alone 77 13 63 10  
External beam ± brachytherapy  63 10 58 9  
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 Respondents  
(N = 629)  
Non-respondentsa 
(N= 654) 
 
 nb % nb % p 
Chemotherapy ± external beam 
radiation or brachytherapy 
69 11 45 7 
Otherc  8 1 12 2  
 
aWomen who had died were excluded 
bNumbers may not sum to total because some data are missing  
cWomen who had hormonal therapy  
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Table 2. The 15 most common needs reported by women with endometrial cancer 3-5 years after diagnosis (N = 629) 
 
 CaSun item description Total Met  Unmet  
Ranka In the last month I needed... N %b %c  Ranka %b CaSUN domain 
1 To know that doctors are talking to each other to coordinate my care 169 27.0% 78%  7 5.9% Comprehensive cancer care 
2 To feel like I was managing my health together with the medical team  168 26.9% 80%  10 5.5% Comprehensive cancer care 
3 Help to reduce stress in my life 149 23.8% 65%  1 8.3% Existential survivorship 
3 Local health care services that were available when I required them 147 23.8% 79%  11 5.0% Comprehensive cancer care 
5 The very best medical care 140 22.5% 81%  15 4.2% Comprehensive cancer care 
6 Help to manage my concerns about the cancer coming back 105 16.8% 57%  4 7.2% Existential survivorship 
7 Help to manage ongoing side effects and/or complications of treatment 103 16.5% 70%  11 5.0% Quality of life 
8 Emotional support to be provided for me 103 16.4% 63%  6 6.1% Existential survivorship 
9 Any complaints regarding my care to be properly addressed 96 15.4% 71%  13 4.5% Comprehensive cancer care 
9 Access complementary and/or alternative therapy services 96 15.4% 72%  14 4.3% Non-specific factor 
11 Help to cope with others not acknowledging the impact that cancer has 
had on my life 
75 12.1% 35%  2 7.9% Existential survivorship 
12 More accessible hospital parking 74 11.7% 43%  5 6.6% Comprehensive cancer care 
13 Help to address problems with my/our sex life 68 10.9% 31%  3 7.5% Relationships 
14 Help to try to make decisions about my life in the context of uncertainty  68 10.8% 46%  7 5.9% Existential survivorship 
15 Help to deal with my own and/or others expectations of me as a “cancer 
survivor”  
60 9.6% 38%  7 5.9% Existential survivorship 
 
a
 Ranking based on total proportion (N = 629) 
bPercentage based on total proportion (N = 629) 
cPercentage based on those reporting a need 
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 Table 3. The association between sociodemographic, clinical, physical and psychosocial 
variables and having an unmet need at 3-5 years after a diagnosis of endometrial cancer 
(N = 629) 
 
 N Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI)a 
MEASURED AT DIAGNOSIS   
Sociodemographics    
Age at diagnosis (years)    
<50 61 5.17 (2.79 - 9.60)* 4.47 (2.09 - 9.56)* 
50-65 346 1.82 (1.18 -2.81)* 1.87 (1.10 - 3.16)* 
     65 222 Referent Referent 
Marital status    
Partner 438 Referent  
Unpartnered  176 1.38 (0.93 - 2.05)  
Education     
High school 302 Referent  
Technical college/ University 327 1.79 (1.23 - 2.60)*  
Employment Status    
Out of the workforce 333 Referent  
Employed  283 1.91 (1.31 - 2.78)*  
Area of residence    
Major cities 397 Referent Referent 
Rural/ Remote 220 0.58 (0.39 - 0.87)* 0.56 (0.34 - 0.92)* 
State recruited in    
NSW 135 Referent  
QLD 193 0.86 (0.52 - 1.43)  
VIC 148 1.02 (0.60 - 1.72)  
SA 68 0.71 (0.35 - 1.44)  
WA 58 0.72 (0.34 - 1.51)  
TAS 27 0.63 (0.22 - 1.77)  
Parity     
      None   111 Referent  
      One or more children             518 0.64 (0.41 - 1.00)  
Clinical variables    
Surgery     
Laparotomy 417 Referent  
Laparoscopic/vaginal  hysterectomy 205 0.81 (0.55 - 1.21)  
Stage of disease at diagnosis (FIGO 2009)   
I 530 Referent Referent 
II-IV 98 2.05 (1.30 - 3.24)* 2.47 (1.38 - 4.45)* 
Grade of disease at diagnosis    
1 326 Referent  
2 163 1.24 (0.80 - 1.92)  
3 140 1.24 (0.79 - 1.97)  
MEASURED 3-5 YEARS POST-DIAGNOSIS   
Clinical variables    
Number of lymph nodes removedb    
0 264 Referent  
1-14 224 1.18 (0.77 - 1.81)  
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 N Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI)a 
      ≥ 15 116 1.78 (1.09 - 2.91)*  
Adjuvant treatmentb    
No 399 Referent  
Yes 217 1.83 (1.26 - 2.67)*  
Physical health variables    
Smoking status     
Never 414 Referent  
Ex 174 1.47 (0.98 - 2.21)  
Current 37 2.86 (1.43 - 5.72)*  
BMI      
≤ 18.50 to 24.99 185 Referent  
25 to 34.99 300 0.95 (0.61 - 1.47)  
35.00 to ≥ 40.00 143 1.42 (0.87 - 2.33)  
Comorbidities (based on Charlson index)c   
0 214 Referent Referent 
1 195 0.54 (0.34 - 0.84)* 0.55 (0.32 - 0.97)* 
≥2 220 0.57 (0.37 - 0.88)* 0.47 (0.27 - 0.82)* 
Cancer-specific physical wellbeing (FACT-EN)  
High 232 Referent Referent 
Low  371 3.36 (2.14 - 5.27)* 1.78 (1.05 - 3.02)* 
Lymphoedema    
Nil 385      Referent Referent 
Swelling only 172 3.01 (2.01 - 4.52)* 2.50 (1.51 - 4.15)* 
Lymphoedema 71 2.03 (1.14 - 3.61)* 1.44 (0.71 - 2.93) 
Psychosocial variables    
Anxiety (HADS)    
Normal  463 Referent Referent 
Subclinical/Clinical  160 4.88 (3.28 - 7.26)* 2.21 (1.31 - 3.72)* 
Depression (HADS)    
Normal  556 Referent Referent 
Subclinical/Clinical  67 5.52 (3.26 - 9.36)* 1.83 (0.90 - 3.74) 
Social Support     
All of the time 299 Referent Referent 
Most of the time 180 1.98 (1.24 - 3.17)* 1.93 (1.12 - 3.36)* 
None/little/some of the time 146 4.65 (2.93 - 7.36)* 3.42 (1.92 - 6.11)* 
 
Note. N = participant numbers as per unadjusted analyses; OR = odds ratio; 95 % CI = 95% confidence interval  
*Statistically significant, p < 0.05 
aAdjusted for variables in this column  
bData was collected 3-5 years after diagnosis  
cData from the initial survey (collected around the time of diagnosis) and follow-up survey data were combined 
to create this variable.  
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